Artiva Biotherapeutics In... (ARTV)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

10.62

0.95%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20
Revenue	33.49M	4.93M	2.00M	-
Cost of Revenue	-	-	-	-
Gross Profit	33.49M	4.93M	2.00M	-
Operating Income	-30.67M	-59.83M	-53.27M	-18.27M
Interest Income	2.54M	1.29M	-	2.00K
Pretax Income	-27.62M	-58.34M	-71.83M	-17.99M
Net Income	-27.70M	-58.39M	-71.83M	-17.99M
Selling & General & Admin	13.91M	20.78M	12.86M	4.43M
Research & Development	50.25M	43.98M	42.41M	13.85M
Other Expenses	-	200.00K	-18.55M	477.00K
Operating Expenses	64.16M	64.76M	55.27M	18.27M
Interest Expense	-	-	-	199.00K
Selling & Marketing Expenses	-	-	-	-
Cost & Expenses	64.16M	64.76M	55.27M	18.27M
Income Tax	72.00K	53.00K	-18.55M	676.00K
Shares Outstanding (Basic)	9.35M	17.58M	17.58M	17.58M
Shares Outstanding (Diluted)	9.35M	17.58M	17.58M	17.58M
EPS (Basic)	-2.96	-3.32	-4.08	-1.02
EPS (Diluted)	-2.96	-3.32	-4.08	-1.02
EBITDA	-28.41M	-58.67M	-71.58M	-17.72M
Depreciation & Amortization	2.27M	1.16M	248.00K	73.00K